{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:34:36Z","timestamp":1770824076581,"version":"3.50.1"},"reference-count":115,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Detection and Prevention"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.cdp.2004.10.001","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T18:34:53Z","timestamp":1110566093000},"page":"133-145","source":"Crossref","is-referenced-by-count":8,"title":["Capacity building for the clinical investigation of AIDS malignancy in East Africa"],"prefix":"10.1016","volume":"29","author":[{"given":"Jackson","family":"Orem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mwanda W.","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecily","family":"Banura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Katongole-Mbidde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona","family":"Ayers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Ghannoum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingfu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen G.","family":"Feigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lederman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scot C.","family":"Remick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cdp.2004.10.001_bib1","unstructured":"Joint United Nations Programme on HIV\/AIDS. AIDS epidemic update, December 2003. Geneva, Switzerland: Joint United Nations Programme on HIV\/AIDS (UNAIDS). Accessioned December 9, 2003 at http:\/www.unaids.org\/[click on AIDS Epidemic Update]."},{"key":"10.1016\/j.cdp.2004.10.001_bib2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/jnci\/94.10.718","article-title":"Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa","volume":"94","author":"Otieno","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cdp.2004.10.001_bib3","first-page":"205","article-title":"The spectrum of non-AIDS-defining neoplastic disease in HIV infection","volume":"44","author":"Remick","year":"1996","journal-title":"J Investig Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0889-8588(05)70394-4","article-title":"Non-AIDS defining cancers","volume":"10","author":"Remick","year":"1996","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.cdp.2004.10.001_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Pallela","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib6","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.285.10.1308","article-title":"Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States","volume":"285","author":"Lee","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cdp.2004.10.001_bib7","first-page":"390","article-title":"The epidemiology of acquired immune deficiency syndrome malignancies","volume":"27","author":"Geodert","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cdp.2004.10.001_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.319.7201.23","article-title":"Risk of HIV-related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study","volume":"319","author":"Ledergerber","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.cdp.2004.10.001_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0140-6736(00)02504-6","article-title":"AIDS across Europe: the EuroSIDA study, 1994\u201398","volume":"356","author":"Mocroft","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cdp.2004.10.001_bib10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cdp.2004.10.001_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ijc.2910540106","article-title":"Cancer in Kampala, Uganda, in 1989\u201391: changes in incidence in the era of AIDS","volume":"54","author":"Wabinga","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1097-0215(19960117)65:2<200::AID-IJC12>3.0.CO;2-H","article-title":"Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection","volume":"65","author":"Ziegler","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib13","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1097\/00002030-199912240-00010","article-title":"AIDS-related cancers in Africa: maturation of the epidemic in Uganda","volume":"13","author":"Parkin","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.cdp.2004.10.001_bib14","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1164\/ajrccm.153.6.8665064","article-title":"Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis","volume":"153","author":"Whalen","year":"1996","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus","volume":"337","author":"Whalen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00042560-199708150-00008","article-title":"HIV-1 risk and vaccine acceptability in the Ugandan military","volume":"15","author":"Hom","year":"1997","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cdp.2004.10.001_bib17","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1086\/315114","article-title":"Depressed T-cell interferon-y responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy","volume":"180","author":"Hirsch","year":"1999","journal-title":"JID"},{"key":"10.1016\/j.cdp.2004.10.001_bib18","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/315868","article-title":"Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in Uganda","volume":"182","author":"Cao","year":"2000","journal-title":"JID"},{"key":"10.1016\/j.cdp.2004.10.001_bib19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1365-2249.2000.01385.x","article-title":"T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and primary tuberculosis (TB)","volume":"122","author":"Hertoghe","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cdp.2004.10.001_bib20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/00002030-200006160-00020","article-title":"Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda","volume":"14","author":"Whalen","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.cdp.2004.10.001_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00042560-200102010-00012","article-title":"Developing AIDS vaccine trials education programs in Uganda","volume":"26","author":"McGrath","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cdp.2004.10.001_bib22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1086\/318817","article-title":"Augmentation of apoptosis and IFN-production at the site of active MTB infection in human tuberculosis","volume":"183","author":"Hirsch","year":"2001","journal-title":"JID"},{"key":"10.1016\/j.cdp.2004.10.001_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2249.2001.01401.x","article-title":"Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients","volume":"123","author":"Toossi","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cdp.2004.10.001_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/bmj.324.7331.226","article-title":"First trial of the HIV-1 vaccine in Africa: Ugandan experience","volume":"324","author":"Mugerwa","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.cdp.2004.10.001_bib25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/368020","article-title":"Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV network for prevention trials 007 vaccine study","volume":"187","author":"Cao","year":"2003","journal-title":"JID"},{"key":"10.1016\/j.cdp.2004.10.001_bib26","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/JCM.36.10.2874-2876.1998","article-title":"Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients","volume":"36","author":"Jessup","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cdp.2004.10.001_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0732-8893(98)00095-9","article-title":"Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Uganda AIDS patients","volume":"32","author":"Pfaller","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cdp.2004.10.001_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1128\/AAC.43.1.169","article-title":"In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa","volume":"43","author":"Pfaller","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cdp.2004.10.001_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/1097-0215(20010601)92:5<687::AID-IJC1246>3.0.CO;2-Z","article-title":"Adult Burkitt's lymphoma in patients with and without human immunodefciency virus infection in Kenya","volume":"92","author":"Mwanda","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib30","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1128\/IAI.68.9.5198-5204.2000","article-title":"Cytokine responses to Plasmodium falciparum liver-stage antigen-1 vary in rainy and dry seasons in highland Kenya","volume":"68","author":"John","year":"2000","journal-title":"Infec Immunol"},{"key":"10.1016\/j.cdp.2004.10.001_bib31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1093-3263(00)00099-1","article-title":"Efficient discovery of immune response targets by cyclical refinement of QSAR (quantitative structure activity relationship) models of peptide binding","volume":"19","author":"Brusic","year":"2001","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.cdp.2004.10.001_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4269\/ajtmh.2002.66.372","article-title":"Lymphocyte proliferation and antibody levels to Plasmodium falciparum liver-stage antigen-1 in an area of highland Kenya with highly seasonal transmission","volume":"66","author":"John","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cdp.2004.10.001_bib33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4049\/jimmunol.168.1.356","article-title":"Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus","volume":"168","author":"King","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cdp.2004.10.001_bib34","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.bjc.6600929","article-title":"Activation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli","volume":"88","author":"MacNeil","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib35","series-title":"Mini-symposium-HIV+ cancer patient care in resource poor countries: 6th international conference on malignancies in AIDS and other immunodeficiencies: basic, epidemiologic and clinical research","article-title":"Considerations for international collaboration in East Africa: Case Western Reserve University (CWRU) experience","author":"Remick","year":"2002"},{"key":"10.1016\/j.cdp.2004.10.001_bib36","series-title":"Mini-symposium-HIV+ cancer patient care in resource poor countries: 6th international conference on malignancies in AIDS and other immunodeficiencies: basic, epidemiologic and clinical research","article-title":"Brief overview of AIDS malignancies and patient care in Uganda","author":"Katongole-Mbidde","year":"2002"},{"key":"10.1016\/j.cdp.2004.10.001_bib37","series-title":"Mini-symposium-HIV+ cancer patient care in resource poor countries: 6th international conference on malignancies in AIDS and other immunodeficiencies: basic, epidemiologic and clinical research","article-title":"Brief overview of AIDS malignancies and patient care in Kenya","author":"Otieno","year":"2002"},{"key":"10.1016\/j.cdp.2004.10.001_bib38","unstructured":"Orem J, Otieno MW, Banura C, et al. Prospective screening for AIDS-related non-Hodgkin's lymphoma (AR-NHL) patients (PTS) in East Africa as part of a clinical trial. Poster presentation at the 7th international conference on malignancies in AIDS and other immunodeficiencies: basic, epidemiologic and clinical research, NIH, Bethesda, MD, April 28\u201329, 2003 [abstract no. 28]."},{"key":"10.1016\/j.cdp.2004.10.001_bib39","unstructured":"Otieno MW, Orem J, Banura C, et al. Preliminary observations using dose-modified oral combination chemotherapy (DMOCC) for AIDS-related non-Hodgkin's lymphoma (AR-NHL) in East Africa: toxicity and vital status. Poster presentation at the 7th international conference on malignancies in AIDS and other immunodeficiencies: basic, epidemiologic and clinical research, NIH, Bethesda, MD, April 28\u201329, 2003 [abstract no. 29]."},{"key":"10.1016\/j.cdp.2004.10.001_bib40","unstructured":"Banura C, Orem J, Otieno MW, et al. CWRU 2498: dose-modified oral combination chemotherapy (DMOCC) for AIDS-related non-Hodgkin's lymphoma in East Africa. Invited oral presentation at the 4th international conference on cancer in Africa sponsored by the African Organization for Research and Training in Cancer (AORTIC), Accra, Ghana, October 6\u201310, 2003."},{"key":"10.1016\/j.cdp.2004.10.001_bib41","unstructured":"Otieno MW, Remick SC, Orem J, et al. HIV-related malignancies in Kenya. Invited oral presentation at the 4th international conference on cancer in Africa sponsored by the African Organization for Research and Training in Cancer (AORTIC), Accra, Ghana, October 6\u201310, 2003."},{"key":"10.1016\/j.cdp.2004.10.001_bib42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"A sarcoma involving the jaws of African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"Br J Surg"},{"key":"10.1016\/j.cdp.2004.10.001_bib43","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-3476(60)80369-1","article-title":"Malignant tumors in African children: with special reference to malignant lymphoma","volume":"56","author":"O\u2019Conor","year":"1960","journal-title":"J Pediat"},{"key":"10.1016\/j.cdp.2004.10.001_bib44","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/274756a0","article-title":"Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study","volume":"274","author":"de-The","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.cdp.2004.10.001_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ijc.2910080116","article-title":"Kaposi's sarcoma in Uganda: a clinico-pathological study","volume":"8","author":"Taylor","year":"1971","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib46","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/bjc.1972.66","article-title":"Kaposi's sarcoma in Uganda: geographic and ethnic distribution","volume":"26","author":"Taylor","year":"1972","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ijc.2910330208","article-title":"Endemic Kaposi's sarcoma in the West Nile district of Uganda","volume":"33","author":"McHardy","year":"1984","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib48","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/0140-6736(93)92252-O","article-title":"Endemic Kaposi's sarcoma and local volcanic soils","volume":"342","author":"Ziegler","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cdp.2004.10.001_bib49","first-page":"305","article-title":"Kaposi's sarcoma and pneumocystis pneumonia among homosexual men-New York City and California","volume":"30","year":"1981","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cdp.2004.10.001_bib50","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0140-6736(81)92740-9","article-title":"Kaposi's sarcoma in homosexual men: a report of eight cases","author":"Hymes","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.cdp.2004.10.001_bib51","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(85)90122-9","article-title":"Slim disease: a new disease in Uganda and its association with HTLV-III infection","volume":"2","author":"Serwadda","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.cdp.2004.10.001_bib52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJM199008093230605","article-title":"AIDS in Uganda: clinical and social features","volume":"323","author":"Goodgame","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib53","first-page":"1585","article-title":"Trends in cancer incidence in Kyadondo County, Uganda","volume":"82","author":"Wabinga","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0140-6736(90)91562-O","article-title":"HIV and conjunctival malignancies","volume":"336","author":"Kestelyn","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cdp.2004.10.001_bib55","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/bjo.80.6.503","article-title":"Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi","volume":"80","author":"Waddell","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.cdp.2004.10.001_bib56","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(95)90870-6","article-title":"Conjunctival squamous cell carcinoma associated with HIV infection in Kampala, Uganda","volume":"345","author":"Ateenyi-Agaba","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cdp.2004.10.001_bib57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0093-7754(01)90092-2","article-title":"Acquired immunodeficiency syndrome-associated cancers in Sub-Saharan Africa","volume":"28","author":"Thomas","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cdp.2004.10.001_bib58","doi-asserted-by":"crossref","unstructured":"Mwanda Wo, Fu P, Collea C, Whalen C, Remick SC. Kaposi's sarcoma in patients with and without human immunodeficiency virus infection in a tertiary referral center in Kenya. Ann Trop Med Parasitol, 2004 [in press].","DOI":"10.1179\/136485905X19928"},{"key":"10.1016\/j.cdp.2004.10.001_bib59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000409700","article-title":"Classical and endemic form of Kaposi's sarcoma: a review","volume":"32","author":"Hutt","year":"1983","journal-title":"Antibiot Chemother"},{"key":"10.1016\/j.cdp.2004.10.001_bib60","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/bjc.1998.717","article-title":"The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic","volume":"78","author":"Cook-Mozaffari","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib61","first-page":"47","article-title":"Kaposi's sarcoma: a comparison of classical, endemic, and epidemic forms","volume":"11","author":"Ziegler","year":"1984","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cdp.2004.10.001_bib62","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0046-8177(98)90258-1","article-title":"HIV-associated malignant lymphomas in Kenya (Equatorial Africa)","volume":"29","author":"Lazzi","year":"1998","journal-title":"Human Pathol"},{"key":"10.1016\/j.cdp.2004.10.001_bib63","unstructured":"The International Network for Cancer Treatment and Research (INCTR) brochure. Institut Pasteur, Brussels, Belgium, 1999."},{"key":"10.1016\/j.cdp.2004.10.001_bib64","first-page":"1101","article-title":"Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection","volume":"10","author":"Mocroft","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.cdp.2004.10.001_bib65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm0302-225","article-title":"HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma","volume":"8","author":"Sgadari","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib66","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1182\/blood.V99.10.3771","article-title":"Antitumor effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma","volume":"99","author":"Pati","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cdp.2004.10.001_bib67","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatits B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib68","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib69","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM199709183371209","article-title":"The ethics of clinical research in the Third World","volume":"337","author":"Angell","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/154510970300200205","article-title":"Ethics and the AIDS pandemic in the developing world","volume":"2","author":"Ahn","year":"2003","journal-title":"J Int Assoc Phys AIDS Care"},{"key":"10.1016\/j.cdp.2004.10.001_bib71","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2307\/3528268","article-title":"Research in developing countries: taking \u201cbenefit\u201d seriously","volume":"26","author":"Glantz","year":"1998","journal-title":"Hastings Cent Rep"},{"key":"10.1016\/j.cdp.2004.10.001_bib72","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199908123410712","article-title":"Proposed revisions to the Declaration of Helsinki: will they weaken the ethical principles underlying human research?","volume":"341","author":"Brennan","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib73","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM199908123410713","article-title":"The need to revise the Declaration of Helsinki","volume":"341","author":"Levine","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib74","unstructured":"World Medical Association Declaration of Helsinki. Revised ed., Hong Kong, China: 41st World Medical Assembly; 1989."},{"key":"10.1016\/j.cdp.2004.10.001_bib75","unstructured":"International ethical guidelines for biomedical research involving human subjects. Geneva, Switzerland: Council for International Organizations of Medical Sciences; 1993."},{"key":"10.1016\/j.cdp.2004.10.001_bib76","series-title":"The ethics of research involving human subjects: facing the 21st century","first-page":"235","article-title":"International codes and guidelines for research ethics: a critical appraisal","author":"Levine","year":"1996"},{"key":"10.1016\/j.cdp.2004.10.001_bib77","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cdp.2004.10.001_bib78","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJM199505043321801","article-title":"Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection","volume":"332","author":"Moore","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib79","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1086\/513997","article-title":"High incidence of Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus in tumor lesions and peripheral blood mononuclear cells from patients with Kaposi's sarcoma in Uganda","volume":"175","author":"Purvis","year":"1997","journal-title":"JID"},{"key":"10.1016\/j.cdp.2004.10.001_bib80","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1600-0560.2001.028004200.x","article-title":"The clonality of tumor-infiltrating lymphcytes in African Kaposi's sarcoma","volume":"28","author":"Nihal","year":"2001","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.cdp.2004.10.001_bib81","series-title":"Mini-symposium-HIV+ cancer patient care in resource poor countries: 6th international conference on malignancies in AIDS and other immunodeficiencies: basic, epidemiologic and clinical research","article-title":"Brief overview of AIDS malignancies and patient care in India","author":"Bharucha","year":"2002"},{"key":"10.1016\/j.cdp.2004.10.001_bib82","series-title":"Mini-symposium-HIV+ cancer patient care in resource poor countries: 6th international conference on malignancies in AIDS and other immunodeficiencies: basic, epidemiologic and clinical research","article-title":"Viral lymphoproliferative diseases in Brazil","author":"Harrington","year":"2002"},{"key":"10.1016\/j.cdp.2004.10.001_bib83","series-title":"Mini-symposium-HIV+ cancer patient care in resource poor countries: 6th international conference on malignancies in AIDS and other immunodeficiencies: basic, epidemiologic and clinical research","article-title":"AIDS-related malignancies in Brazil","author":"Brites","year":"2002"},{"key":"10.1016\/j.cdp.2004.10.001_bib84","unstructured":"ACS Resource. The AIDS Cancer and Specimen Resource: National Cancer Institute (Bethesda, MD, USA). Accessioned on December 22, 2003 at http:\/\/acsb.ucsf.edu [click on Specimens and News]."},{"key":"10.1016\/j.cdp.2004.10.001_bib85","first-page":"2402","article-title":"O6-Benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair","volume":"59","author":"Spiro","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.cdp.2004.10.001_bib86","first-page":"2971","article-title":"Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation","volume":"7","author":"Dowlati","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cdp.2004.10.001_bib87","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1200\/JCO.2001.19.8.2309","article-title":"Phase I clinical and pharmacokinetic study of rebeccamycin analog (NSC 655649) given daily for 5 consecutive days","volume":"19","author":"Dowlati","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cdp.2004.10.001_bib88","first-page":"5929","article-title":"Phase I and correlative study of combination bryostatin 1 and vincristine in refractory B-cell malignancies","volume":"9","author":"Dowlati","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cdp.2004.10.001_bib89","first-page":"3408","article-title":"A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin A-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer","volume":"62","author":"Dowlati","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cdp.2004.10.001_bib90","first-page":"101","article-title":"Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity","volume":"52","author":"Horung","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.cdp.2004.10.001_bib91","first-page":"1305","article-title":"Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts","volume":"4","author":"Al-Katib","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cdp.2004.10.001_bib92","first-page":"165","article-title":"Successful treatment of human Waldenstrom's macroglobulinemia with combination biological and chemotherapy agents","volume":"54","author":"Mohammad","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.cdp.2004.10.001_bib93","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0145-2126(95)00037-O","article-title":"Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma","volume":"19","author":"Mohammad","year":"1995","journal-title":"Leuk Res"},{"key":"10.1016\/j.cdp.2004.10.001_bib94","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/028418602317314127","article-title":"Preclinical evaluations of therapies combining the vascular targeting agent combretastatin A-4 disodium phosphate and conventional anticancer therapies in the treatment of Kaposi's sarcoma","volume":"41","author":"Li","year":"2002","journal-title":"Acta Oncol"},{"key":"10.1016\/j.cdp.2004.10.001_bib95","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/028418602317314136","article-title":"Activity of the vascular targeting agent combretastatin A-4 disodium phosphate in a xenograft model of AIDS-associated Kaposi's sarcoma","volume":"41","author":"Rojiani","year":"2002","journal-title":"Acta Oncol"},{"key":"10.1016\/j.cdp.2004.10.001_bib96","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1089\/aid.1996.12.1659","article-title":"Perspsective: research highlighsts at the Case Western Reserve University Center for AIDS research","volume":"12","author":"LeGrice","year":"1996","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.cdp.2004.10.001_bib97","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1200\/JCO.1993.11.9.1691","article-title":"Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin lymphoma","volume":"11","author":"Remick","year":"1993","journal-title":"J Clin Oncol"},{"issue":"Suppl. 3","key":"10.1016\/j.cdp.2004.10.001_bib98","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00003495-199958003-00014","article-title":"Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignancies","volume":"58","author":"Remick","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.cdp.2004.10.001_bib99","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/1096-8652(200103)66:3<178::AID-AJH1042>3.0.CO;2-H","article-title":"Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF, quality of life analysis and long-term follow-up","volume":"66","author":"Remick","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cdp.2004.10.001_bib100","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low-dose compared with standard dose m BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib101","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","article-title":"Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy","volume":"19","author":"Ratner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cdp.2004.10.001_bib102","first-page":"126","article-title":"P-5340: A phase I pharmacokinetic study of STI571 in patients (pts) with advanced malignancies and varying degrees of renal dysfunction","volume":"22","author":"Remick","year":"2003","journal-title":"Proc ASCO"},{"key":"10.1016\/j.cdp.2004.10.001_bib103","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1128\/JVI.76.16.8383-8399.2002","article-title":"Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells","volume":"76","author":"Moses","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.cdp.2004.10.001_bib104","unstructured":"Koon H, Bubley G, Pantanowitz L, et al. AIDS-related Kaposi's sarcoma: imatinib mesylate-induced regression in c-kit positive disease. Oral presentation at the 7th international conference on malignancies in AIDS and other immunodeficiencies: basic, epidemiologic and clinical research, NIH, Bethesda, MD, April 28\u201329; 2003 [abstract no. 20]."},{"key":"10.1016\/j.cdp.2004.10.001_bib105","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/jnci\/85.22.1812","article-title":"Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor induction in vivo","volume":"85","author":"Philip","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cdp.2004.10.001_bib106","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/bjc.1995.356","article-title":"A phase I trial of bryostatin 1 in patients with advanced malignancy using 24-hour intravenous infusion","volume":"72","author":"Jayson","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib107","first-page":"482","article-title":"A phase I clinical and pharmacodynamic study of all-trans retonoic acid and bryostatin 1 in patients with advanced malignancies","volume":"15","author":"Toppmeyer","year":"1996","journal-title":"Proc ASCO"},{"key":"10.1016\/j.cdp.2004.10.001_bib108","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.1998.16.1.56","article-title":"Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia","volume":"6","author":"Varterasian","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cdp.2004.10.001_bib109","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/bjc.1993.352","article-title":"A phase I study of intravenous bryostatin 1 in patients with advanced cancer","volume":"68","author":"Prendiville","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4049\/jimmunol.140.2.433","article-title":"Immunomodulating properties of a novel series of protein kinase C activators: the bryostatins","volume":"140","author":"Trenn","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.cdp.2004.10.001_bib111","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199610313351803","article-title":"Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus","volume":"335","author":"Kovacs","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cdp.2004.10.001_bib112","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ijc.10274","article-title":"Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi's sarcoma or non-Hodgkin lymphoma","volume":"98","author":"Tam","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cdp.2004.10.001_bib113","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/00002030-200307040-00028","article-title":"Relapse of Kaposi's sarcoma in HIV-infected patients switching from a protease inhibitor to a non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimen","volume":"17","author":"Bani-Sadr","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.cdp.2004.10.001_bib114","unstructured":"Mutuluza Kityo C. Access to antiretroviral therapy (ART): the Joint clinical research center (JCRC) experience. Uganda Society for Health Sciences Newsletter 2002;3(1):2."},{"key":"10.1016\/j.cdp.2004.10.001_bib115","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/jnci\/95.22.1651","article-title":"Cancer in the developing world: how should care be delivered and research conducted?","volume":"95","author":"Bruckbauer","year":"2003","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Detection and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361090X04001564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361090X04001564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T16:46:49Z","timestamp":1683046009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361090X04001564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0361090X04001564"],"URL":"https:\/\/doi.org\/10.1016\/j.cdp.2004.10.001","relation":{},"ISSN":["0361-090X"],"issn-type":[{"value":"0361-090X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}